Vaccines train the body's defenses to fight infections safely. Learn how vaccines work, how the immune system responds, and ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

Among mRNA tech, vaccines have been the primary target of the federal ... to protein-construction sites where the complex ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors. Research reported recently in the journal Nature ...

Moderna’s market value has fallen by more than 90% — $185 billion, or a full Sony — from its 2021 peak to around $10 billion ...

A stunning new study offers early evidence that Covid-19 vaccines might have a secret superpower: a precisely timed mRNA shot could help many cancer patients live longer.

Scientists have developed an experimental mRNA vaccine that, when combined with existing immunotherapy drugs, could 'teach' ...

University of Florida Health writer Michelle Jaffee reports a bold finding: cancer patients who got a COVID-19 mRNA vaccine ...

A large-scale MIT screen of tuberculosis proteins revealed several possible antigens that could be developed as a new vaccine for TB, the world’s deadliest infectious disease.